Alzheimer’s Drug Slows Progression – New Hope?

For Renato Anghinah, neurologist and associate professor at the Faculty of Medicine of the University of São Paulo (FMUSP), the advance paves the way for the development of new medicines, with the potential to achieve even greater efficacy. “At each step, we advance, albeit slowly, but always bringing more hope for the future. It’s a high-cost medicine that still doesn’t deliver everything expected, but it’s already much better than what we had until now”, he highlights.